Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 35,421 shares at $34.63 ($1.2M) on 2021-06-21, disclosed to the SEC on 2021-06-23.
Open-market sale of $1.2M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.80 | 2,556 | $86K | 7.1% |
| 2 | $33.80 | 2,556 | $86K | 7.1% |
| 3 | $34.63 | 14,006 | $485K | 39.8% |
| 4 | $34.63 | 14,006 | $485K | 39.8% |
| 5 | $33.36 | 1,486 | $50K | 4.1% |
| 6 | $34.09 | 189 |
| $6K |
| 0.5% |
| 7 | $32.98 | 622 | $21K | 1.7% |
| Total | $34.43 avg | 35,421 | $1.2M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |